# LEVOTHYROXINE SODIUM
> **NDA202231** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2011-06-24
## Drug
- **FDA Application Number:** NDA202231
- **Application type:** New Drug Application
- **Brand name:** LEVOTHYROXINE SODIUM
- **Generic name:** LEVOTHYROXINE SODIUM ANHYDROUS
- **Active ingredients:** LEVOTHYROXINE SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2011-06-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202231)
---
*MORVS · CC0 1.0*